SCHEMBL31101161

SCHEMBL31101161

Nc1nnc(-c2cc(F)ccc2O)cc1N1CCN(Cc2ccc(N3CCC(=O)NC3=O)nc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 7/20 0.39
▸ SMARCA4 P51532 7/20 0.39
▸ PBRM1 Q86U86 6/20 0.39
▸ NR1I2 O75469 2/20 0.39
▸ OPRM1 P35372 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ PARP1 P09874 3/20 0.36
▸ PARP2 Q9UGN5 1/20 0.36
▸ CRBN Q96SW2 7/20 0.36
▸ DDB1 Q16531 6/20 0.36
▸ IKZF3 Q9UKT9 6/20 0.36
▸ DRD2 P14416 2/20 0.35
▸ ADRA1D P25100 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ ADRA1B P35368 1/20 0.35
▸ TNK2 Q07912 1/20 0.34
▸ TNK1 Q13470 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31100500 0.90 PBRM1 (0.50) SMARCA2SMARCA4PBRM1NR1I2CRBN
SCHEMBL31101071 0.89 PBRM1 (0.41) SMARCA2SMARCA4PBRM1NR1I2CRBN
SCHEMBL31102957 0.85 PBRM1 (0.41) SMARCA2SMARCA4PBRM1NR1I2CRBN
SCHEMBL31103189 0.84 PBRM1 (0.39) SMARCA2SMARCA4PBRM1NR1I2PARP1
SCHEMBL31330889 0.81 PBRM1 (0.39) SMARCA2SMARCA4PBRM1NR1I2PARP1
SCHEMBL31099658 0.80 CRBN (0.42) SMARCA2SMARCA4PBRM1NR1I2CRBN
SCHEMBL31331350 0.80 PBRM1 (0.38) SMARCA2SMARCA4PBRM1NR1I2PARP1
SCHEMBL31101965 0.78 PBRM1 (0.53) SMARCA2SMARCA4PBRM1NR1I2CRBN
SCHEMBL38662829 0.78 PBRM1 (0.45) SMARCA2SMARCA4PBRM1NR1I2DRD2
SCHEMBL31100448 0.77 PBRM1 (0.52) SMARCA2SMARCA4PBRM1NR1I2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678638-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-01-14 — — EP claimed
WO-2024188209-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-09-19 — — WO claimed
EP-4678638-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-01-14 — — EP disclosed
WO-2024188209-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-09-19 — — WO disclosed
Send feedback